KAMADA LTD SEC filings

Filings

1. 6-KKAMADA LTDKMDAOct 6

   Kamada Ltd expands biosimilars portfolio in Israel

   • Launched two new biosimilars: Ustekinumab-Kamada and Enoxaparin-Kamada.
   • Expected biosimilars revenue to reach $10M in 2028 and $20M-$25M by 2030.
   • Plans to launch at least two more biosimilars in 2027.
2. 6-KKAMADA LTDKMDAOct 5

   Kamada Ltd. responds to SEC comments

   • Filed 6-K on 2026-10-05
   • Responded to SEC comment letter dated 2026-09-25
   • Mentioned no capitalization of pre-approval inventory costs for 2025 and 2024
3. 4KAMADA LTDKMDASep 29

   3 insider filings

   Lilach Asher-Topilsky, insider filing for KMDA

   Show all 3

   • 4Insider filing for KMDASep 29
   • 4Insider filing for KMDASep 29
   • 4Insider filing for KMDASep 29

   Lilach Asher-Topilsky, reporting

4. 4KAMADA LTDKMDASep 25

   Amir London, insider filing for KMDA

   Amir London, reporting

5. 4KAMADA LTDKMDASep 24

   3 insider filings

   Boris Gorelik, insider filing for KMDA

   Show all 3

   • 4Insider filing for KMDASep 24
   • 4Insider filing for KMDASep 24
   • 4Insider filing for KMDASep 24

   Boris Gorelik, reporting

6. 4KAMADA LTDKMDASep 24

   2 insider filings

   Karnit Goldwasser, insider filing for KMDA

   Show all 2

   • 4Insider filing for KMDASep 24
   • 4Insider filing for KMDASep 24

   Karnit Goldwasser, reporting

7. 4KAMADA LTDKMDASep 23

   4 insider filings

   Nir Livneh, insider filing for KMDA

   Show all 4

   • 4Insider filing for KMDASep 23
   • 4Insider filing for KMDASep 23
   • 4Insider filing for KMDASep 23
   • 4Insider filing for KMDASep 23

   Nir Livneh, reporting

8. 4KAMADA LTDKMDASep 23

   4 insider filings

   Eran Nir, insider filing for KMDA

   Show all 4

   • 4Insider filing for KMDASep 23
   • 4Insider filing for KMDASep 23
   • 4Insider filing for KMDASep 23
   • 4Insider filing for KMDASep 23

   Eran Nir, reporting

9. 4KAMADA LTDKMDASep 23

   2 insider filings

   Yael Brenner, insider filing for KMDA

   Show all 2

   • 4Insider filing for KMDASep 23
   • 4Insider filing for KMDASep 23

   Yael Brenner, reporting

10. 4KAMADA LTDKMDASep 17

    3 insider filings

    Yael Brenner, insider filing for KMDA

    Show all 3

    • 4Insider filing for KMDASep 17
    • 4Insider filing for KMDASep 17
    • 4Insider filing for KMDASep 17

    Yael Brenner, reporting

11. 6-KKAMADA LTDKMDASep 17

    Foreign issuer report

12. EFFECTKAMADA LTDKMDASep 16

    Registration declared effective

13. 4KAMADA LTDKMDASep 11

    David Tsur, insider filing for KMDA

    David Tsur, reporting

14. 6-KKAMADA LTDKMDASep 10

    Foreign issuer report

15. F-3KAMADA LTDKMDASep 9

    Securities offering

16. 4KAMADA LTDKMDASep 8

    2 insider filings

    David Tsur, insider filing for KMDA

    Show all 2

    • 4Insider filing for KMDASep 8
    • 4Insider filing for KMDASep 8

    David Tsur, reporting

17. 6-KKAMADA LTDKMDASep 3

    Foreign issuer report

18. 4KAMADA LTDKMDAAug 31

    Yael Brenner, insider filing for KMDA

    Yael Brenner, reporting

19. SCHEDULE 13G/AKAMADA LTDKMDAAug 20

    Ownership stake disclosure by Phoenix Financial Ltd. (amended)

    Phoenix Financial Ltd., filed by

20. 6-KKAMADA LTDKMDAAug 17

    Foreign issuer report

21. 6-KKAMADA LTDKMDAAug 12

    Foreign issuer report

22. 4KAMADA LTDKMDAAug 6

    9 insider filings

    Benjamin Dekel, insider filing for KMDA

    Show all 9

    • 4Insider filing for KMDAAug 6
    • 4Insider filing for KMDAAug 6
    • 4Insider filing for KMDAAug 6
    • 4Insider filing for KMDAAug 6
    • 4Insider filing for KMDAAug 6
    • 4Insider filing for KMDAAug 6
    • 4Insider filing for KMDAAug 6
    • 4Insider filing for KMDAAug 6
    • 4Insider filing for KMDAAug 6

    Benjamin Dekel, reporting

23. 6-KKAMADA LTDKMDAAug 5

    Foreign issuer report

24. 6-KKAMADA LTDKMDAAug 5

    Foreign issuer report

25. 6-KKAMADA LTDKMDAJul 20

    Foreign issuer report

26. 6-KKAMADA LTDKMDAJul 13

    Foreign issuer report

27. 6-KKAMADA LTDKMDAJun 18

    Foreign issuer report

Older filings on EDGAR